Haug Partners is a full-service, national law firm that provides integrated multidisciplinary legal services for life science and technology companies. Our service offerings include: (i) Antitrust Litigation and Counseling; (ii) Commercial Litigation and Strategic Counseling; (iii) Due Diligence; (iv) FDA Compliance and Counseling; (v) Intellectual Property Enforcement; (vi) Intellectual Property Procurement and Strategy; (vii) International Trade Commission; (viii) Investigations, Compliance, and Risk Mitigation Services; (ix) Licensing and Transactions; and (x) Trademarks and Unfair Competition. With offices in New York, Washington, D.C., and Boston, and through relationships with firms in Germany, China, Japan, and other key international markets, Haug Partners has the resources, technical expertise, legal acumen, and business judgment to consistently deliver optimal outcomes for clients. The firm was founded in 1997 as Frommer Lawrence and Haug and adopted the Haug Partners name in March 2017.
BioPharma Law Group, PLLC is a law firm that serves life sciences companies, including biotechnology, pharmaceutical, and medical device companies, at all stages. We provide efficient, focused, and practical legal advice and solutions to enable life science companies to meet their intellectual property and corporate goals and needs.
We represent life sciences companies, with a focus on the biotechnology, pharmaceutical, and medical device sectors. Our list of clients includes innovator and generic/biosimilar companies, sponsor companies and manufacturers, start-ups and mid-stage companies, public and private companies, universities, investors, as well as individual entrepreneurs, scientists, engineers, and physicians.
Andrew Wasson is a partner in the New York office of Haug Partners. Andrew has a broad range of experience in both the brand and generic side of pharmaceuticals, especially with respect to issues involving intellectual property law and regulatory law. Having grown up with a father who is a patent lawyer, Mr. Wasson has been involved in patents in one way or another for the better part of his life and has the advantage of being able to deal with complex patent law concepts in a very natural way. Mr. Wasson is registered to practice before the U.S. Patent and Trademark Office and has published extensively in both scientific and legal literature. Mr. Wasson also serves on the Editorial Advisory Board for FDLI's Update Magazine.
Joanna is the Owner and Principal of BioPharma Law Group, PLLC. She is a patent attorney who focuses her practice on all aspects of services related to patents in the life sciences. Joanna has experience counseling clients on the Hatch-Waxman Act and is monitoring developments involving biosimilars under the Biologics Price Competition and Innovation Act. Joanna is also a former Adjunct Lecturer at the Harvard T.H. Chan School of Public Health and the current Editor-in-Chief of the Journal of Commercial Biotechnology. She regularly speaks or lectures on intellectual property-related topics and is a frequent author of articles related to patent law and healthcare. In 2013, Joanna published a book called Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health which examines the relationship between patents and public health in the context of medical technologies. In 2014, Joanna was selected to the National Law Journal’s list of Boston’s Rising Stars. Joanna received her J.D. degree from Boston College Law School, and is admitted to the Massachusetts and New York State Bars as well as the USPTO.